服务热线
021-60498804
产品中心
/ Products Classification 点击展开+| Cat. Number | 733980163235736 |
| Chemical Name | Mesna-d4 (contain disulfide) |
| CAS Number | 1189479-73-9 |
| Category | Aliphatics, Isotope Labelled Compounds, Sulfur & Selenium Compounds |
| Mol. Formula | C2HD4NaO3S2 |
| Mol. Weight | 168.20 |
| Qty 1 |
5mg |
| Qty 2 | 50mg |
| Appearance | White to Off-White Solid |
| Application Notes | Mesna reacts with acrolein and other urotoxic metabolites of oxazaphosphorines (cyclophosphamide or ifosfamide) to form stable, non-urotoxic compounds. Mesna does not have any antitumour activity, nor does it appear to interfere with the antitumour activity of antineoplastic drugs. This medication is used to protect the bladder wall from the harmful effects of some cancer-fighting drugs. |
| Synonym | 2-Mercaptoethanesulfonic-d4 Acid Sodium Salt; 2-Mercapto-1-ethanesulfonic-d4 Acid Monosodium Salt; D 7093-d4; Mesnex-d4; Mistabron-d4; Mistabronco-d4; Mucofluid-d4; Sodium 2-Mercaptoethanesulfonate-d4; UCB 3983-d4; Uromitexan-d4 |
| Melting Pt. | >200°C |
| Boiling Pt. | N/A |
| Solubility | DMSO (Slightly), Water (Slightly) |
| Stability | Unstable in solution |
| References | Tekeres, M., et al.: Clin. Ther., 4, 56 (1981), Brock, N., et al.: Eur. J. Cancer Clin Oncol., 18, 1377 (1982), James, C.A., et al.: Br. J. Clin. Pharmacol., 23, 561 (1987), Schoenike, S.E., et al.: Clin. Pharm., 9, 179 (1990), |
Copyright © 2022 上海惠诚生物科技有限公司
沪ICP备2021037845号-6
